ReviewCurrent opinion in HIV and AIDS2026
Public health surveillance and outbreak preparedness for mpox.
Review in Current opinion in HIV and AIDS, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Development and clinical validation of a colorimetric isothermal assay for rapid detection of monkeypox virus.New microbes and new infections · 2026Article
- A comprehensive overview of monkeypox virus disease.Tropical medicine and health · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purpose of reviewThe 2022 global mpox outbreak showed that surveillance systems were not ready to quickly detect or adapt to the new dynamic of human-to-human spread. While many lessons were learned, ongoing mpox outbreaks underscore the need for focused attention on enhancing mpox surveillance systems. This review presents ongoing challenges, successes, recent advances, and future considerations for seven areas related to surveillance for mpox. RECENT
findingsThe development of real-time polymerase chain reaction assays has greatly improved MPXV detection, though there remain diagnostic gaps and critical needs for expanding genomic surveillance. Challenges to complete case ascertainment, data sharing, and reporting also persist. At the same time, key advances have been made regarding the integration of mpox into existing surveillance and healthcare service delivery for HIV and sexually transmitted infections; use of the One Health approach to understand the interconnectedness of human, animal, and environmental health; and application of newer innovations in surveillance efforts such as wastewater monitoring and artificial intelligence. SUMMARY: This review highlights recent work that informs how to maintain nimble, sustainable, and coordinated surveillance systems that will not only strengthen the response to the evolving mpox outbreaks but also contribute to future pandemic preparedness initiatives.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.